1)Ang KK, et al:Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
2)Qu H, et al:Prognostic value of Epstein-Barr virus DNA level for nasopharyngeal carcinoma:a meta-analysis of 8128 cases. Eur Arch Otorhinolaryngol 277:9-18, 2020
3)Ahn SM, et al:Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. JAMA Otolaryngol Head Neck Surg 140:846-854, 2014
4)Sawicka M, et al:The specificity and patterns of staining in human cells and tissues of p16INK4a antibodies demonstrate variant antigen binding. PLoS One 8:e53313, 2013
5)Shelton J, et al:p16 immunohistochemistry in oropharyngeal squamous cell carcinoma:a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status. Mod Pathol 30:1194-1203, 2017
6)Lin JC, et al:Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350:2461-2470, 2004
7)Alsofyani AA, et al:Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes. Cancer Biomark 28:213-220, 2020
8)Chen CC, et al:Human papillomavirus-related carcinoma with adenoid cystic-like features of the sinonasal tract(also known as human papillomavirus-related multiphenotypic sinonasal carcinoma). Arch Pathol Lab Med 143:1420-1424, 2019